
Stream Neuroscience is a private, international biotechnology company focused on developing small molecule therapies for challenging neurological disorders. Unlike conventional therapies that target proteins outside the cell, Stream Neuroscience's innovative approach targets molecules deep within brain cells to regulate biological pathways involved in neurological diseases. Their patented machine-learning drug discovery platform has identified novel therapies with pre-clinical efficacy for Focal Onset Epilepsy, Generalized Epilepsy, and Developmental and Epileptic Encephalopathies, aiming to restore brain health. The company was co-founded by experts in pediatric neurology, epileptology, and neuropharmacology, with a strong emphasis on leveraging scientific innovation and a proprietary drug discovery platform.

Stream Neuroscience is a private, international biotechnology company focused on developing small molecule therapies for challenging neurological disorders. Unlike conventional therapies that target proteins outside the cell, Stream Neuroscience's innovative approach targets molecules deep within brain cells to regulate biological pathways involved in neurological diseases. Their patented machine-learning drug discovery platform has identified novel therapies with pre-clinical efficacy for Focal Onset Epilepsy, Generalized Epilepsy, and Developmental and Epileptic Encephalopathies, aiming to restore brain health. The company was co-founded by experts in pediatric neurology, epileptology, and neuropharmacology, with a strong emphasis on leveraging scientific innovation and a proprietary drug discovery platform.